Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/26/2014US20140179657 Method for producing carotenoid composition
06/26/2014US20140179656 Neurogenesis screening method and uses thereof
06/26/2014US20140179655 Solid oral dosage form of testosterone derivative
06/26/2014US20140179652 Steroidal Compositions
06/26/2014US20140179651 Ciclesonide for the treatment of airway disease in horses
06/26/2014US20140179650 Pharmaceutical formulation comprising ciclesonide
06/26/2014US20140179649 Compositions and methods for the treatment of skin diseases
06/26/2014US20140179648 Novel Heterocyclic Compounds as Bromodomain Inhibitors
06/26/2014US20140179647 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors
06/26/2014US20140179646 Hormone delivery system and method
06/26/2014US20140179644 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
06/26/2014US20140179640 Topical compositions for the treatment of dermatological disorders
06/26/2014US20140179639 Meloxicam for the treatment of respiratory diseases in pigs
06/26/2014US20140179637 Methods and compounds to inhibit enveloped virus release
06/26/2014US20140179635 Tumor eradication by inositol-tripyrophosphate
06/26/2014US20140179633 Composition comprising pyrazino-triazine derivatives
06/26/2014US20140179630 Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma
06/26/2014US20140179629 Slowly digesting starch and fermentable fiber
06/26/2014US20140179626 Acadesine derivatives, products and compositions including same, therapuetic uses thereof, and methods for synthesizing same
06/26/2014US20140179625 Sodium channel blockers
06/26/2014US20140179623 Ectoparasiticidal active substance combinations
06/26/2014US20140179622 Novel compound isolated from quamoclit, and composition for preventing or treating diabetes containing the compound as an active ingredient
06/26/2014US20140179618 Novel cancer therapies and methods
06/26/2014US20140179616 Peptides that stimulate subcutaneous adipogenesis
06/26/2014US20140179615 Glutathione and Acetaminophen Composition and Preparation Method Thereof
06/26/2014US20140179606 Left ventricular diastolic function improving agent
06/26/2014US20140178511 Levothyroxine formulation with acacia
06/26/2014US20140178509 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
06/26/2014US20140178507 Weight management composition
06/26/2014US20140178503 Cyclohexyl urea modulators of d2 receptors and/or d3 receptors
06/26/2014US20140178497 Thrush treatment paste
06/26/2014US20140178494 Methods of treating gastrointestinal spasms in a subject having diverticulitis
06/26/2014US20140178492 Bowel cleansing composition
06/26/2014US20140178488 Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans
06/26/2014US20140178487 Camel hump oil - based herbal compositions and method of making the same
06/26/2014US20140178484 Multi-particulate pharmaceutical composition
06/26/2014US20140178479 Concentrated Felbamate Formulations for Parenteral Administration
06/26/2014US20140178477 Solid preparation
06/26/2014US20140178476 Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
06/26/2014US20140178475 Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same
06/26/2014US20140178474 Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentation
06/26/2014US20140178473 Solid dosage form
06/26/2014US20140178472 Methods of Regulating Glucose Metabolism, and Reagents Related Thereto
06/26/2014US20140178471 Multi-layered release formulation
06/26/2014US20140178470 Dispersible tablet
06/26/2014US20140178469 Stable benzimidazole formulation
06/26/2014US20140178468 Multiparticulate extended-release composition of mesalamine
06/26/2014US20140178466 Steroidal Compositions
06/26/2014US20140178465 Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
06/26/2014US20140178464 Cholestanol derivative for combined use
06/26/2014US20140178463 Compositions for treating cmt and related disorders
06/26/2014US20140178462 Amphoteric liposomes comprising neutral lipids
06/26/2014US20140178461 Compounds and compositions for use in the treatment and prevention of lung and brain cancer and precancerous conditions thereof
06/26/2014US20140178459 Compositions and methods for transdermal delivery of hormones and other medicinal agents
06/26/2014US20140178458 Medicinal skin protection composition with an active ingredient combination which improves the skin barrier
06/26/2014US20140178456 Methods and compositions for treating type 2 diabetes and related conditions
06/26/2014US20140178452 Anti-Proliferative and Anti-Inflammatory Agent Combination for Treatment of Vascular Disorders with an Implantable Medical Device
06/26/2014US20140178449 Methods for treating parkinson's disease
06/26/2014US20140178447 Reduction of biofilms on medical devices
06/26/2014US20140178441 Pharmaceutical formulation for reducing frequency of urination and method of use thereof
06/26/2014US20140178439 Capture of pathogenic and non-pathogenic biopolymers and bioparticles
06/26/2014US20140178434 Method and compositions
06/26/2014US20140178416 Cross-linkers and their uses
06/26/2014US20140178403 Method of inhibiting binding or activity of mif by administering a mif antagonist
06/26/2014US20140178399 Role of adam10 and its relevance to disease and therapeutics
06/26/2014US20140178374 Bax agonist, compositions, and methods related thereto
06/26/2014US20140178372 Methods of treating hematologic cancers
06/26/2014US20140178371 Anti-angiogenesis therapy for the treatment of ovarian cancer
06/26/2014US20140178370 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
06/26/2014US20140178369 Treatment with anti-vegf antibodies
06/26/2014US20140178366 Preselection of subjects for therapeutic treatment based on hypoxic status
06/26/2014US20140178360 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
06/26/2014US20140178354 Salinosporamides and Methods of Use Thereof
06/26/2014US20140178349 Cycloalkyl-Substituted Imidazole Derivative
06/26/2014US20140178340 Cancer combination therapy and recombinant vectors
06/26/2014US20140178338 4'-fluoro nuclosides for the treatment of hcv
06/26/2014US20140178337 Hepatitis b antiviral agents
06/26/2014US20140178336 Antiviral compounds
06/26/2014US20140178331 Method of treating cerebral hemorrhage and subarachnoid hemorrhage comprising administering metal chelators to the upper one-third of the nasal cavity
06/26/2014US20140178314 Compositions and/or articles with improved solubility of a solid active
06/26/2014US20140178311 Method of adding botanical agents/dietary supplements to pharmaceutical agents in a pharmacotherapeutic regimen
06/26/2014US20140178308 Method for increasing the intraocular pressure in an animal
06/26/2014US20140178300 Theranostic imaging agents and methods of use
06/26/2014US20140175330 Delivery methods and composition relating to bioactice polyelectrolyte acids from humified organic materials
06/26/2014US20140174440 Dry powder inhaler and methods of use
06/26/2014US20140174437 Dry powder inhaler and methods of use
06/26/2014DE102012025005A1 Use of resveratrol and/or their analogues e.g. for treating platelet aggregation and cancellation of resistance to acetylsalicylic acid or nonsteroidal anti-inflammatory drugs and/or repealing paradoxical reaction to acetylsalicylic acid
06/25/2014EP2746404A1 Antitumor agent and therapeutic effect prediction method for patients with kras-mutated colorectal cancer
06/25/2014EP2746396A1 Selective local inhibition of TNFR1-mediated functions at the site of antigen/allergen presentation
06/25/2014EP2746286A1 Aminated derivative of homoharringtonine, preparation method therefor, and application thereof
06/25/2014EP2746285A1 Process for the preparation of aurora kinase inhibitors
06/25/2014EP2746284A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof
06/25/2014EP2746283A1 Pyrimidopyrimidone derivatives, pharmaceutical compositions and uses thereof
06/25/2014EP2746282A1 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer
06/25/2014EP2746281A2 7-azaindole derivatives
06/25/2014EP2746280A1 Novel compound isolated from quamoclit, and composition for preventing or treating diabetes containing the compound as an active ingredient
06/25/2014EP2746272A1 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
06/25/2014EP2746269A1 Alicyclic[c]benzopyrone derivatives and uses thereof
06/25/2014EP2746268A1 Method for chemical synthesis of antrocin and use thereof for suppressing non-small cell lung cancer
06/25/2014EP2746265A1 Heterocyclic derivative and pharmaceutical drug
1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 7860